nwbo stock price — NWBO Overview

NWBO (Northwest Biotherapeutics, Inc.) — Stock price

This article explains nwbo stock price and what investors and observers should know when following Northwest Biotherapeutics, Inc. (NWBO). It covers the ticker and listing details, the typical stock metrics you’ll see, representative historical values, price history and drivers, trading liquidity characteristics, fundamentals, analyst coverage, corporate events that move the stock, regulatory and clinical‑development impacts, risks, monitoring sources and data provenance. Read on to learn where to find live or delayed nwbo stock price quotes, how to interpret OTC data, and which corporate items historically link to price moves.

As of 2026-01-28, per market-data providers such as MarketWatch and Yahoo Finance, representative 52-week ranges for NWBO have been reported around the $0.17–$0.48 band and recent quoted prices often trade in the low $0.20–$0.30 area; remember nwbo stock price figures are time‑sensitive and vary by source and snapshot.

Company overview

Northwest Biotherapeutics, Inc. (NWBO) is a U.S.-based biotechnology company focused on developing personalized dendritic-cell immunotherapies, primarily through its DCVax platform. Founded in the 1990s and headquartered in Bethesda, Maryland, the firm’s business model centers on research and clinical development of dendritic-cell vaccines intended to stimulate a patient’s immune response against cancer. NWBO’s pipeline and value proposition are tied closely to DCVax‑related clinical trials, manufacturing scalability, and potential commercialization agreements. For investors, nwbo stock price is a reflection of progress (or setbacks) in that development and the company’s financing and operational posture.

Ticker and listing details

• Ticker: NWBO
• Listing: Quoted on U.S. Over‑The‑Counter (OTC) markets (vendors may show OTCQB, OTCMKTS, or similar designations)
• Trading currency: USD

Because NWBO trades OTC, nwbo stock price quotes are often delayed on public portals, can show wider bid‑ask spreads, and may reflect lower regulatory and reporting uniformity compared with major U.S. exchanges. OTC quotation also tends to produce greater intraday price jumps on thinner volume and can make accurate real‑time pricing harder to obtain through retail aggregators.

Key stock metrics (what to expect in this section)

In an NWBO stock price profile you will commonly see the following metrics:

• Share price (last trade / bid / ask)
• Market capitalization
• Shares outstanding
• Public float
• Trailing EPS (if available; often negative for development‑stage biotech)
• Price‑to‑earnings ratio (often not meaningful for loss‑making firms)
• 52‑week high / low
• Average daily volume (trading liquidity over 30/60/90 days)

All of these values are time‑sensitive and reported by market‑data providers; readers should expect small discrepancies between services.

Typical historical values (examples drawn from market data)

Representative figures reported by market data providers for nwbo stock price history (note: illustrative and variable by source): 52‑week range approximately $0.17–$0.48; recent quoted price often seen in the low $0.20–$0.30 range; market‑cap estimates frequently reported in the low hundreds of millions USD depending on the source and the share count used. These are example ranges to set expectations — always confirm live numbers from a current market feed.

Price history and performance

This section explains how nwbo stock price is reported across multiple timeframes and why a reader should look beyond a single snapshot. Typical timeframes include intraday ticks, daily close, 1‑month, year‑to‑date (YTD), 1‑year and multi‑year performance.

OTC microcap biotechs like NWBO often exhibit volatile nwbo stock price behavior driven by thin trading, discrete news items (clinical updates, financings), and occasional retail interest surges. Historical performance can feature long periods of low activity punctuated by sharp spikes or drops after company announcements.

Notable historical price milestones

• Listing / timeline: NWBO has a long listing history in OTC markets; significant milestones for the stock typically track clinical‑trial progress and financings.
• Clinical results and trial news: Press releases with interim or final data for DCVax candidates have historically led to noticeable intraday or multi‑day nwbo stock price moves.
• Financing events: Announcements of convertible notes, registered direct offerings, or equity raises commonly trigger dilution concerns and can depress nwbo stock price absent offsetting positive news.
• Recorded extremes: OTC microcaps can register both multi‑year lows and short‑term spikes; consult historical charts from primary providers for exact all‑time highs/lows.

All historical milestones should be cross‑checked with the company’s press releases and SEC or OTC disclosure filings for verification.

Trading characteristics and liquidity

OTC biotechs like NWBO typically show the following trading characteristics:

• Average daily volume: often ranges from mid‑100,000s shares to several million shares on high‑interest days. Volume can spike around corporate or clinical news.
• Liquidity and spreads: Wider bid/ask spreads are common, particularly outside U.S. market hours; retail orders may experience partial fills or price slippage for larger sizes.
• Execution considerations: Market orders can lead to adverse execution in thin markets; limit orders are preferable to control entry/exit prices when tracking nwbo stock price.

Understanding these traits helps interpret short‑term nwbo stock price changes and manage order execution expectations.

Fundamentals and financial performance

Northwest Biotherapeutics, like many development‑stage biotech firms, typically reports:

• Revenue profile: Limited or minimal product revenue due to focus on clinical development and precommercial activities.
• Profitability: Historically negative net income and negative EPS driven by research & development expenses and general & administrative costs.
• Cash and liquidity: Cash, burn rate, and available financing lines are key drivers of nwbo stock price; short cash runways or announced financings can amplify volatility.

Biotech valuations often rest more on clinical prospects and pipeline milestones than on near‑term GAAP earnings; investors should treat nwbo stock price as sensitive to trial updates and financing news.

Analyst coverage, forecasts and price targets

Analyst coverage for OTC microcaps such as NWBO may be limited or uneven. When coverage exists, price targets and forecasts can vary widely between providers and often include greater uncertainty than coverage for large‑cap names.

Third‑party forecasting websites and independent analysts sometimes publish bullish or bearish scenarios for nwbo stock price, but these should be treated cautiously. Divergence between services is typical; verify assumptions behind any target (e.g., patient‑population assumptions, partnership timing, dilution scenarios).

Corporate events and financings that affect price

Key corporate events that historically affect nwbo stock price include:

• Equity raises and registered offerings: Increase shares outstanding and dilute existing holders, often pressuring price.
• Convertible debt or note financings: Can introduce future dilution depending on conversion terms.
• Strategic partnerships or licensing agreements: May be perceived positively if they accelerate commercialization or provide non‑dilutive funding.
• Manufacturing and supply agreements: Critical for a cell‑therapy company; milestones here can affect perceived commercial readiness and influence nwbo stock price.

Investors should track filings (SEC or OTC disclosures) and press releases to assess the impact of such events on share count and dilution risk.

Regulatory and clinical development impact

Clinical trial outcomes, regulatory authority interactions, and manufacturing milestones are central to NWBO’s value proposition and therefore to nwbo stock price. Examples of drivers:

• Positive trial readouts or favorable safety/efficacy signals can cause significant upward moves.
• Negative data, trial terminations, or unexpected safety issues typically produce sharp declines.
• Regulatory approvals, expanded access programs, or constructive meetings with regulators can be market catalysts.

For NWBO specifically, DCVax candidate progress and QC/CMC (quality control / chemistry, manufacturing, and controls) milestones are often the most direct factors behind meaningful nwbo stock price swings.

Risks and investor considerations

Major risk categories to consider when following nwbo stock price:

• Clinical‑development risk: Efficacy or safety failures in DCVax programs could materially affect valuation and nwbo stock price.
• Regulatory risk: Uncertainty in approval pathways or requests for additional data can delay commercialization.
• Financing and dilution risk: Frequent capital raises may dilute existing shareholders and put downward pressure on nwbo stock price.
• OTC‑specific risks: Lower reporting scrutiny and thinner liquidity compared with major exchanges mean nwbo stock price may be more volatile and less transparent.
• Financial red flags: Repeated operating losses, short cash runways, or material weaknesses in reporting (as disclosed) are typical red flags in this sector.

This is a factual risk summary for monitoring purposes and not investment advice.

How to monitor NWBO stock price

Practical tips to monitor nwbo stock price reliably:

1. Use multiple market‑data sources to cross‑check US OTC quotes (see Common data sources below). OTC quotes may be delayed on some portals — confirm timestamp of the quote.
2. Check the company’s investor relations announcements and OTC/SEC filings for primary confirmations of events that could move nwbo stock price.
3. Watch volume spikes: sudden volume increases accompanying a news item often signal institution or retail interest and pronounced nwbo stock price reaction.
4. Prefer limit orders in OTC stocks to avoid unexpected fills caused by wide spreads.
5. For real‑time needs, use a broker platform with direct OTC quoting or an institutional feed; public portals may show last trade but not real‑time best bid/ask.

As of 2026-01-28, per MarketWatch and Yahoo Finance, nwbo stock price quotations are commonly presented with a delay on free portals; always verify trade timestamps before making decisions.

Common data sources (examples)

Investors and data aggregators commonly consult the following providers for nwbo stock price and related metrics:

• Yahoo Finance
• MarketWatch
• MarketBeat
• StockAnalysis
• GuruFocus
• StockTwits (for sentiment and community posts)
• TradingView (charting and scripting)
• Robinhood (retail quote displays)
• Stockscan

Note: reported metrics (market cap, float, average volume) can differ slightly between providers due to different data‑update cadences and share‑count assumptions.

Ownership, major holders and float considerations

When evaluating nwbo stock price behavior, ownership structure matters:

• Insider holdings: Company filings disclose executive and board holdings; substantial insider stakes can align management with shareholders but also concentrate voting power.
• Institutional holdings: OTC microcaps may have limited institutional ownership; when institutions participate, their trades can magnify nwbo stock price movements.
• Float vs. outstanding shares: A small public float relative to total outstanding shares can amplify price moves because fewer shares are available for trading.

Review the latest company filings and authorized reports for up‑to‑date ownership tables before making judgments based on ownership concentration.

Related securities and comparators

For comparative analysis of nwbo stock price, investors often look at other small‑cap biotech tickers developing cell‑based or immune‑oncology therapies. When making comparisons, use peers with similar development stages, market caps and pipeline risk to contextualize valuation and volatility. There are no known ADRs or foreign listings for NWBO; the company is primarily quoted on the U.S. OTC markets.

References and data provenance

This article synthesizes information commonly reported by market‑data vendors and the company’s public disclosures. Primary sources used to construct the outline and sample metrics include (examples): Yahoo Finance, MarketWatch, Robinhood, StockTwits, MarketBeat, StockAnalysis, GuruFocus and Stockscan. Always cross‑check nwbo stock price figures against the firm’s filings and real‑time broker feeds.

As of 2026-01-28, according to MarketWatch and Yahoo Finance, representative nwbo stock price ranges and market metrics described earlier are reflected in public summaries; readers should verify current values in an up‑to‑date feed before acting on them.

See also

• OTC markets (overview and differences vs. exchanges)
• Clinical‑trial risk in biotech investing
• Stock‑valuation metrics for development‑stage companies
• DCVax technology (dendritic‑cell immunotherapies)
• Investor relations: how to read SEC and OTC filings

Further exploration and next steps

If you want to follow nwbo stock price regularly, start by bookmarking a few primary data sources, set up alerts for NWBO press releases, and review company filings for share‑count and financing updates. For tools to monitor market sentiment and charts, try charting platforms and community sentiment feeds. To manage crypto and Web3 asset workflows, consider Bitget Wallet; for broader market‑monitoring features, explore Bitget’s market tools and research offerings to complement your financial‑market workflow.

This article is informational and neutral in tone. It summarizes common market data, historical drivers and monitoring practices for nwbo stock price without providing investment advice. For precise trading or portfolio actions, consult licensed financial professionals and verify live market data.